{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:12:45Z","timestamp":1778875965298,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["MOLT-4\/CCR5"],"award-info":[{"award-number":["MOLT-4\/CCR5"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI49170"],"award-info":[{"award-number":["AI49170"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001117","name":"amfAR, The Foundation for AIDS Research","doi-asserted-by":"publisher","award":["108838-55-RGRL"],"award-info":[{"award-number":["108838-55-RGRL"]}],"id":[{"id":"10.13039\/100001117","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001117","name":"amfAR, The Foundation for AIDS Research","doi-asserted-by":"publisher","award":["108686-54-RGRL"],"award-info":[{"award-number":["108686-54-RGRL"]}],"id":[{"id":"10.13039\/100001117","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["377790"],"award-info":[{"award-number":["377790"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT 149075"],"award-info":[{"award-number":["PJT 149075"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["385787"],"award-info":[{"award-number":["385787"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ebiom.2020.102853","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T08:58:04Z","timestamp":1594285084000},"page":"102853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infection"],"prefix":"10.1016","volume":"59","author":[{"given":"Jamie F.S.","family":"Mann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Pankrac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul F.","family":"McKay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah F.L.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanuka N.","family":"Wijewardhana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Pawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodi","family":"Meyerowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Canaday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Avino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Art F.Y.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Fidler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin J.","family":"Shattock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4880-7968","authenticated-orcid":false,"given":"Eric J.","family":"Arts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ebiom.2020.102853_bib0001","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007161","article-title":"HIV-1 antiretroviral drug therapy","volume":"2","author":"Arts","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ebiom.2020.102853_bib0002","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fimmu.2013.00052","article-title":"Do HIV-specific CTL continue to have an antiviral function during antiretroviral therapy? If not, why not, and what can be done about it?","volume":"4","author":"McIlroy","year":"2013","journal-title":"Front Immunol"},{"issue":"24","key":"10.1016\/j.ebiom.2020.102853_bib0003","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1073\/pnas.94.24.13193","article-title":"Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy","volume":"94","author":"Chun","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5341","key":"10.1016\/j.ebiom.2020.102853_bib0004","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102853_bib0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00002030-200401020-00005","article-title":"Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level","volume":"18","author":"Viard","year":"2004","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102853_bib0006","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/8394","article-title":"Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy","volume":"5","author":"Finzi","year":"1999","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102853_bib0007","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"Siliciano","year":"2003","journal-title":"Nat Med"},{"issue":"7408","key":"10.1016\/j.ebiom.2020.102853_bib0008","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/487439a","article-title":"HIV: shock and kill","volume":"487","author":"Deeks","year":"2012","journal-title":"Nature"},{"issue":"8447","key":"10.1016\/j.ebiom.2020.102853_bib0009","article-title":"Activation and lysis of human CD4 cells latently infected with HIV-1","volume":"6","author":"Pegu","year":"2015","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102853_bib0010","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1172\/JCI80142","article-title":"Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations","volume":"125","author":"Laird","year":"2015","journal-title":"J Clin Investig"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102853_bib0011","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nm.3489","article-title":"New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo","volume":"20","author":"Bullen","year":"2014","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102853_bib0012","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/infdis\/jis412","article-title":"Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy","volume":"206","author":"Blazkova","year":"2012","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102853_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004287","article-title":"Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes","volume":"10","author":"Jones","year":"2014","journal-title":"PLoS Pathog"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102853_bib0014","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.4156","article-title":"Defective proviruses rapidly accumulate during acute HIV-1 infection","volume":"22","author":"Bruner","year":"2016","journal-title":"Nat Med"},{"issue":"6884","key":"10.1016\/j.ebiom.2020.102853_bib0015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/417095a","article-title":"HIV preferentially infects HIV-specific CD4+ T cells","volume":"417","author":"Douek","year":"2002","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102853_bib0016","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1089\/aid.2010.0363","article-title":"Short communication: HIV antigen-specific reactivation of HIV infection from cellular reservoirs: implications in the settings of therapeutic vaccinations","volume":"28","author":"Shete","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102853_bib0017","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1172\/JCI200421318","article-title":"The immune response to AIDS virus infection: good, bad, or both?","volume":"113","author":"Deeks","year":"2004","journal-title":"J Clin Investig"},{"key":"10.1016\/j.ebiom.2020.102853_bib0018","doi-asserted-by":"crossref","first-page":"e18889","DOI":"10.7554\/eLife.18889","article-title":"Establishment and stability of the latent HIV-1 DNA reservoir","volume":"5","author":"Brodin","year":"2016","journal-title":"Elife"},{"issue":"513","key":"10.1016\/j.ebiom.2020.102853_bib0019","doi-asserted-by":"crossref","first-page":"eaaw5589","DOI":"10.1126\/scitranslmed.aaw5589","article-title":"The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation","volume":"11","author":"Abrahams","year":"2019","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102853_bib0020","article-title":"A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system","volume":"3","author":"Pankrac","year":"2018","journal-title":"NPJ Vaccines"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102853_bib0021","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/nm1295-1284","article-title":"In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency","volume":"1","author":"Chun","year":"1995","journal-title":"Nat Med"},{"issue":"5374","key":"10.1016\/j.ebiom.2020.102853_bib0022","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1126\/science.281.5374.266","article-title":"Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents","volume":"281","author":"Poon","year":"1998","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102853_bib0023","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1128\/JVI.74.7.3105-3111.2000","article-title":"Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation","volume":"74","author":"Stewart","year":"2000","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102853_bib0024","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.immuni.2018.04.030","article-title":"Targeting the Latent Reservoir for HIV-1","volume":"48","author":"Sengupta","year":"2018","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102853_bib0025","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1073\/pnas.97.3.1178","article-title":"HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4(+) T cells","volume":"97","author":"Cicala","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102853_bib0026","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood.V99.5.1666","article-title":"Increased sensitivity of T lymphocytes to tumor necrosis factor receptor 1 (TNFR1)- and TNFR2-mediated apoptosis in HIV infection: relation to expression of Bcl-2 and active caspase-8 and caspase-3","volume":"99","author":"de Oliveira Pinto","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2020.102853_bib0027","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.virol.2014.02.008","article-title":"Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure","volume":"454-455","author":"Mbonye","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.ebiom.2020.102853_bib0028","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41541-017-0040-6","article-title":"A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system","volume":"3","author":"Pankrac","year":"2018","journal-title":"NPJ Vaccines"},{"issue":"21","key":"10.1016\/j.ebiom.2020.102853_bib0029","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0802203105","article-title":"Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection","volume":"105","author":"Keele","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102853_bib0030","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1086\/315260","article-title":"Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy","volume":"181","author":"Gunthard","year":"2000","journal-title":"J Infect Dis"},{"issue":"8808","key":"10.1016\/j.ebiom.2020.102853_bib0031","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/0140-6736(92)91321-X","article-title":"HIV-1 viraemia and influenza","volume":"339","author":"Ho","year":"1992","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102853_bib0032","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood.V86.3.1082.1082","article-title":"Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination","volume":"86","author":"O'Brien","year":"1995","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.ebiom.2020.102853_bib0033","doi-asserted-by":"crossref","first-page":"F145","DOI":"10.1097\/00002030-199814000-00001","article-title":"Increase in plasma viral load after oral cholera immunization of HIV-infected subjects","volume":"12","author":"Ortigao-de-Sampaio","year":"1998","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102853_bib0034","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1084\/jem.182.6.1727","article-title":"Activation of virus replication after vaccination of HIV-1-infected individuals","volume":"182","author":"Staprans","year":"1995","journal-title":"J Exp Med"},{"issue":"15","key":"10.1016\/j.ebiom.2020.102853_bib0035","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1097\/QAD.0000000000001201","article-title":"Standard vaccines increase HIV-1 transcription during antiretroviral therapy","volume":"30","author":"Yek","year":"2016","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102853_bib0036","doi-asserted-by":"crossref","first-page":"e30176","DOI":"10.1371\/journal.pone.0030176","article-title":"A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs","volume":"7","author":"Lassen","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102853_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003834","article-title":"An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients","volume":"9","author":"Spina","year":"2013","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102853_bib0038","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1084\/jem.20170193","article-title":"Proliferation of latently infected CD4(+) T cells carrying replication-competent HIV-1: potential role in latent reservoir dynamics","volume":"214","author":"Hosmane","year":"2017","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102853_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003174","article-title":"Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies","volume":"9","author":"Eriksson","year":"2013","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102853_bib0040","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","article-title":"Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure","volume":"155","author":"Ho","year":"2013","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102853_bib0041","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ebiom.2015.06.019","article-title":"A novel assay to measure the magnitude of the inducible viral reservoir in HIV-infected individuals","volume":"2","author":"Procopio","year":"2015","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102853_bib0042","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.4049\/jimmunol.1600055","article-title":"HIV Protease inhibitor-induced cathepsin modulation alters antigen processing and cross-presentation","volume":"196","author":"Kourjian","year":"2016","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102853_bib0043","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.4049\/jimmunol.1302805","article-title":"Sequence-specific alterations of epitope production by HIV protease inhibitors","volume":"192","author":"Kourjian","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2020.102853_bib0044","doi-asserted-by":"crossref","first-page":"38313","DOI":"10.1038\/srep38313","article-title":"Limited HIV-1 reactivation in resting CD4(+) T cells from aviremic patients under protease inhibitors","volume":"6","author":"Kumar","year":"2016","journal-title":"Sci Rep"},{"issue":"18","key":"10.1016\/j.ebiom.2020.102853_bib0045","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1073\/pnas.85.18.6612","article-title":"Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A","volume":"85","author":"Seelmeier","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102853_bib0046","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1073\/pnas.91.6.2171","article-title":"Endosomal aspartic proteinases are required for invariant-chain processing","volume":"91","author":"Maric","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102853_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1083\/jcb.96.1.1","article-title":"Endocytosis and the recycling of plasma membrane","volume":"96","author":"Steinman","year":"1983","journal-title":"J Cell Biol"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102853_bib0048","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1182\/blood-2007-04-084814","article-title":"Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation","volume":"111","author":"Schade","year":"2008","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102853_bib0049","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"Hutter","year":"2009","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ebiom.2020.102853_bib0050","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","article-title":"Evidence for the cure of HIV infection by CCR5Delta32\/Delta32 stem cell transplantation","volume":"117","author":"Allers","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2020.102853_bib0051","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","article-title":"HIV-1 remission following CCR5Delta32\/Delta32 haematopoietic stem-cell transplantation","volume":"568","author":"Gupta","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.102853_bib0052","series-title":"Proceedings of Conference on Retroviruses and Opportunistic Infections","article-title":"Analytic treatment interruption (ATI) after allogeneic CCR5-D32 HSCT for AML in 2013","volume":"394B","author":"Jensen BOK","year":"2019"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102853_bib0053","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/aid.2008.0191","article-title":"Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid","volume":"25","author":"Archin","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102853_bib0054","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005063","article-title":"An in-depth comparison of latency-reversing agent combinations in various in vitro and ex vivo HIV-1 latency models identified bryostatin-1+JQ1 and ingenol-B+JQ1 to potently reactivate viral gene expression","volume":"11","author":"Darcis","year":"2015","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102853_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004156","article-title":"Dynamics of HIV latency and reactivation in a primary CD4+ T cell model","volume":"10","author":"Mohammadi","year":"2014","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102853_bib0056","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.immuni.2012.01.014","article-title":"Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation","volume":"36","author":"Shan","year":"2012","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102853_bib0057","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.chom.2016.07.015","article-title":"Single-cell characterization of viral translation-competent reservoirs in HIV-infected individuals","volume":"20","author":"Baxter","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"7742","key":"10.1016\/j.ebiom.2020.102853_bib0058","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-019-0898-8","article-title":"A quantitative approach for measuring the reservoir of latent HIV-1 proviruses","volume":"566","author":"Bruner","year":"2019","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102853_bib0059","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/infdis\/jiv582","article-title":"Therapeutic vaccination with dendritic cells loaded with autologous HIV Type 1-infected apoptotic cells","volume":"213","author":"Macatangay","year":"2016","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102853_bib0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/QAI.0000000000000926","article-title":"Dendritic cell immunotherapy for HIV-1 infection using autologous HIV-1 RNA: a randomized, double-blind, placebo-controlled clinical trial","volume":"72","author":"Jacobson","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102853_bib0061","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/aid.2017.0071","article-title":"Immunogenicity of AGS-004 dendritic cell therapy in patients treated during acute HIV infection","volume":"34","author":"Gay","year":"2018","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102853_bib0062","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm806","article-title":"Therapeutic dendritic-cell vaccine for simian AIDS","volume":"9","author":"Lu","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2020.102853_bib0063","doi-asserted-by":"crossref","unstructured":"Gandhi RT, O'Neill D, Bosch RJ, Chan ES, Bucy RP, Shopis J, Baglyos L, Adams E, Fox L, Purdue L, et\u00a0al. A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy. Vaccine. 2009;27(43):6088-94.","DOI":"10.1016\/j.vaccine.2009.05.016"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420302280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420302280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:32:28Z","timestamp":1778873548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420302280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":63,"alternative-id":["S2352396420302280"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102853","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infection","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102853","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102853"}}